Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 32652 | HLA-D (HLA-D) | aplastic anemia | NA | prednisone | NA | unclassified | |
| a patient with aplastic anemia who was found to be homozygous for an hla-d determinant shared by her unrelated parents achieved sustained engraftment and full restoration of hematopoietic and lymphoid function following a transplant from an hla-a and -b nonidentical, abo incompatible sibling who was heterozygous for the shared hla-d specificity. | |||||||
| 32652 | HLA-A (HLA-A) | aplastic anemia | NA | prednisone | NA | unclassified | |
| a patient with aplastic anemia who was found to be homozygous for an hla-d determinant shared by her unrelated parents achieved sustained engraftment and full restoration of hematopoietic and lymphoid function following a transplant from an hla-a and -b nonidentical, abo incompatible sibling who was heterozygous for the shared hla-d specificity. | |||||||
| 34792 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | negation | |
| to determine whether allogeneic bone-marrow transplantation is associated with a graft-versus-leukemia effect, we examined the relation between relapse of leukemia and graft-versus-host disease in 46 recipients of identical-twin (syngeneic) marrow, 117 recipients of hla-identical-sibling (allogeneic) marrow with no or minimal graft-versus-host disease, and 79 recipients of allogeneic marrow with moderate to severe or chronic disease. | |||||||
| 34792 | HLA IDENTICAL (HLA-IDENTICAL) | leukemia | NA | NA | NA | negation | |
| to determine whether allogeneic bone-marrow transplantation is associated with a graft-versus-leukemia effect, we examined the relation between relapse of leukemia and graft-versus-host disease in 46 recipients of identical-twin (syngeneic) marrow, 117 recipients of hla-identical-sibling (allogeneic) marrow with no or minimal graft-versus-host disease, and 79 recipients of allogeneic marrow with moderate to severe or chronic disease. | |||||||
| 34792 | HLA IDENTICAL (HLA-IDENTICAL) | graft-versus-host disease | NA | NA | NA | negation | |
| to determine whether allogeneic bone-marrow transplantation is associated with a graft-versus-leukemia effect, we examined the relation between relapse of leukemia and graft-versus-host disease in 46 recipients of identical-twin (syngeneic) marrow, 117 recipients of hla-identical-sibling (allogeneic) marrow with no or minimal graft-versus-host disease, and 79 recipients of allogeneic marrow with moderate to severe or chronic disease. | |||||||
| 34792 | HLA IDENTICAL (HLA-IDENTICAL) | chronic disease | NA | NA | NA | negation | |
| to determine whether allogeneic bone-marrow transplantation is associated with a graft-versus-leukemia effect, we examined the relation between relapse of leukemia and graft-versus-host disease in 46 recipients of identical-twin (syngeneic) marrow, 117 recipients of hla-identical-sibling (allogeneic) marrow with no or minimal graft-versus-host disease, and 79 recipients of allogeneic marrow with moderate to severe or chronic disease. | |||||||
| 34792 | HLA IDENTICAL (HLA-IDENTICAL) | relapse | NA | NA | NA | negation | |
| to determine whether allogeneic bone-marrow transplantation is associated with a graft-versus-leukemia effect, we examined the relation between relapse of leukemia and graft-versus-host disease in 46 recipients of identical-twin (syngeneic) marrow, 117 recipients of hla-identical-sibling (allogeneic) marrow with no or minimal graft-versus-host disease, and 79 recipients of allogeneic marrow with moderate to severe or chronic disease. | |||||||
| 43062 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | NA | hepatitis | NA | unclassified | |
| NA | |||||||
| 43062 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | NA | hepatitis | NA | unclassified | |
| NA | |||||||
| 59584 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| the major histocompatibility system in man, the hla region, considered to control the immunologic response to transplantation and perhaps to certain diseases, is discussed in relation to chromosomal location, chromosomal mapping, association with other markers, nomenclature of the gene products (the hla antigens), inheritance of the hla antigens, and methods of determining these antigens. | |||||||
Copyright 2024